RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

IntelliSpace Radiation Oncology

Product
Developers: Philips Healthcare
Date of the premiere of the system: May, 2019
Branches: Pharmaceutics, medicine, health care

2019: Announcement

At the beginning of May, 2019 the Philips Healthcare company provided at an annual meeting of the European society of a radiology and oncology in Milan the system of optimization of workflows for departments of radiation therapy of IntelliSpace Radiation Oncology.

Workflows in department of an onkorentgenologiya, as a rule, consist of a set of stages, from issue of the direction to the patient prior to treatment, each of which demands check and a statement. At the same time the specialist is faced by a set of tasks - carrying out simulation visualization, mapping of a tumor and drawing up plans of treatment.

Philips provided the system of maintaining cancer patients of patients

The intelligent solution on flow control of patients of IntelliSpace should increase efficiency in departments of radiation therapy. The IntelliSpace system is based on advanced software for visualization and data analysis. It not only optimizes workflow, but also provides safe data exchange between systems in hospital networks. The platform, open, independent of the supplier, is configured according to specific needs of department or the specialist and provides confidentiality of data and acceptable compatibility with all IT environment of hospital.

Besides, Philips intends to provide at a meeting of Radiation Oncology Practice Management — service of support of adoption of clinical solutions which analyzes data and represents them in a format, convenient for the specialist, for high-quality ensuring work. Also Philips is going to expand a solution portfolio for calculation of a dose of radiotheraphy using the MRCAT AI system. A system allows to estimate fabric density according to the only MRT-picture of a brain. Along with MRCAT of a basin and a prostate gland this system will allow doctors to calculate radiotheraphy doses without additional inspections.

Installation of new solutions on pilot platforms will take place in the second quarter 2019.[1]

Notes